HEALTH & FAMILY
RSV
BUSINESS
Tariff wars to hit popular US-made drugs in China, regulator data shows
BUSINESS
Malaysia approves GSK’s Arexvy vaccine for RSV
BUSINESS
EU approves Moderna’s RSV vaccine for over 60s
BUSINESS
GSK shares fall after sales of top two vaccines disappoint
BUSINESS
US FDA approves Moderna’s RSV vaccine for older adults
BUSINESS
Pfizer, GSK’s new RSV vaccines on track for US$2bil in sales
BUSINESS
GSK sues Pfizer over patents for RSV vaccine
BUSINESS